SciSight Ecosystem
WoS ESCI Q3Scopus Q2SCImago #10,154CAS 4区Hybrid

Journal of Diabetes and Metabolic Disorders

Country: United Kingdom•WoS SCIE Quartile: Q3•Scopus SJR: 0.583•SCImago Rank: #10,154•Identifier (ISSN):2251-6581(Print)•Articles / Year: 228•Estimated Publication Fee (APC): $3,000 USD
Clarivate JCR Index Advisory: Active (ESCI)
Clarivate IF (2026)Q3
2.1
↑ +0.5

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (Hirsch Index)
53

53 papers with at least that number of citations each

WoS: ESCIQ3
Self-Citation Rate5.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
228articles/year
10.77% Gold OA•76.79% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q3(IF: 2.1)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20261.50đ
WoS Q3(IF: 2.1)
🔵 Computed
20251.50đ
WoS Q3(IF: 1.6)
🔵 Computed
20241.50đ
WoS Q3(IF: 1.8)
🔵 Computed
20231.50đ
WoS Q3(IF: 2.8)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Journal of Diabetes & Metabolic Disorders is a peer reviewed journal which publishes original clinical and translational articles and reviews in the field of endocrinology and provides a forum of debate of the highest quality on these issues. Topics of interest include, but are not limited to, diabetes, lipid disorders, metabolic disorders, osteoporosis, interdisciplinary practices in endocrinology, cardiovascular and metabolic risk, aging research, obesity, traditional medicine, pychosomatic research, behavioral medicine, ethics and evidence-based practices.As of Jan 2018 the journal is published by Springer as a hybrid journal with no article processing charges. All articles published before 2018 are available free of charge on springerlink.Unofficial 2017 2-year Impact Factor: 1.816.

Topics Covered (Recognized by AI)
Medicine99.6%Biology97.4%Endocrinology91.5%Internal medicine91%Diabetes mellitus81.7%Pathology69.6%Chemistry54.8%Biochemistry53.2%Genetics36.7%Mathematics32.3%Biotechnology31.7%Insulin30.8%Type 2 diabetes30.7%Statistics29.3%Psychology28.8%Obesity28.2%Sociology28%Surgery21.5%Environmental health20.8%Demography20.7%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,154Scopus Q2SCImago Profile
Scopus Coverage:2012-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.583

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q2
Scopus H-Index (2025)
53

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
2.15

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,000 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations1,394
3-Year Documents586
Citable Documents572

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ2
Endocrinology, Diabetes and MetabolismQ3

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区ENDOCRINOLOGY & METABOLISM
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Springer Nature
Publication Language
English
Frequency
2 issues per year
Indexing & Databases
ESCIScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
ENDOCRINOLOGY & METABOLISM
JCRESCI
148/198Q3
ENDOCRINOLOGY & METABOLISM
JCIESCI
158/198Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—257113
20251.6277632
20241.8167770
20232.81941,142
2022—2352,226
2021—2403,378
2020—2135,689
2019—951,865
2018—46884
2017—492,477
2016—19504
2015—1293,462
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Journal of Diabetes and Metabolic Disorders

WoS Q3
12342023202420251.60
Annual Impact Factor Metric
2025:1.6

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 5.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 52af1d22-931f-453c-b82e-e27ad246f5b5
Database Updated: 2026-09-29